Tumor cells could release extracellular exosomes carrying most of the PD-L1 produced upon IFN-γ stimulation (instead of transporting it to the cell surface), thus suppressing the T cell function and contributing to the resistance to PD-L1 blockade treatment [201]. The gene discussed is IFNG; the disease is neoplasm.